Phase 3 cepheus study of bortezomib, lenalidomide, and dexamethasone with or without daratumumab in transplant-ineligible or trans-plant-deferred patients with newly diagnosed multiple myeloma (NDMM) Meeting Abstract
| Authors: | Usmani, S. Z.; Facon, T.; Hungria, V.; Bahlis, N. J.; Venner, C. P.; Zweegman, S. |
| Abstract Title: | Phase 3 cepheus study of bortezomib, lenalidomide, and dexamethasone with or without daratumumab in transplant-ineligible or trans-plant-deferred patients with newly diagnosed multiple myeloma (NDMM) |
| Meeting Title: | 50th Annual Congress of the Oncology Nursing Society (ONS) |
| Journal Title: | Oncology Nursing Forum |
| Volume: | 52 |
| Issue: | 2 |
| Meeting Dates: | 2025 Apr 9-13 |
| Meeting Location: | Denver, CO |
| ISSN: | 0190-535X |
| Publisher: | Oncology Nursing Society (ONS) |
| Date Published: | 2025-03-01 |
| Start Page: | 16 |
| Language: | English |
| ACCESSION: | WOS:001520221100021 |
| PROVIDER: | wos |
| DOI: | 10.1188/25.ONF.E14 |
| Notes: | Meeting Abstract: I35 -- Source: Wos |
